NASDAQ:JAZZ - Jazz Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$129.63 -0.15 (-0.12 %)
(As of 04/24/2019 10:30 AM ET)
Previous Close$129.78
Today's Range$128.5950 - $130.91
52-Week Range$113.52 - $184.00
Volume73,889 shs
Average Volume673,976 shs
Market Capitalization$7.40 billion
P/E Ratio10.59
Dividend YieldN/A
Beta1.23

Analyst Ratings

Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Jazz Pharmaceuticals in the last 12 months. Their average twelve-month price target is $184.25, suggesting that the stock has a possible upside of 42.14%. The high price target for JAZZ is $210.00 and the low price target for JAZZ is $135.00. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.822.822.822.82
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $184.25$184.8750$190.4375$193.00
Price Target Upside: 42.14% upside36.39% upside47.91% upside23.72% upside

Jazz Pharmaceuticals (NASDAQ:JAZZ) Consensus Price Target History

Price Target History for Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/27/2019MizuhoReiterated RatingNeutral ➝ Hold$137.00 ➝ $147.00MediumView Rating Details
3/26/2019Cantor FitzgeraldReiterated RatingBuy$185.00MediumView Rating Details
3/19/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$163.00MediumView Rating Details
3/19/2019Wells Fargo & CoSet Price TargetBuy$162.00LowView Rating Details
3/18/2019Royal Bank of CanadaSet Price TargetBuy$184.00LowView Rating Details
3/8/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $135.00MediumView Rating Details
2/27/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$199.00 ➝ $206.00MediumView Rating Details
2/13/2019CowenReiterated RatingBuy$200.00MediumView Rating Details
12/23/2018OppenheimerSet Price TargetBuy$180.00MediumView Rating Details
12/14/2018Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLowView Rating Details
11/14/2018HC WainwrightReiterated RatingHold$161.00MediumView Rating Details
11/8/2018B. RileyLower Price TargetBuy ➝ Buy$219.00 ➝ $190.00MediumView Rating Details
11/7/2018Piper Jaffray CompaniesSet Price TargetBuy$208.00HighView Rating Details
8/17/2018Leerink SwannBoost Price TargetOutperform$200.00 ➝ $210.00LowView Rating Details
8/9/2018Seaport Global SecuritiesReiterated RatingBuy$207.00LowView Rating Details
8/8/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$180.00 ➝ $205.00HighView Rating Details
7/13/2018Evercore ISIReiterated RatingBuyLowView Rating Details
7/10/2018CitigroupBoost Price TargetBuy ➝ Buy$162.00 ➝ $205.00LowView Rating Details
2/20/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$164.00 ➝ $170.00LowView Rating Details
1/16/2018Deutsche BankSet Price TargetBuy$170.00MediumView Rating Details
11/8/2017UBS GroupLower Price TargetBuy$172.00 ➝ $168.00N/AView Rating Details
10/19/2017FBR & CoInitiated CoverageBuy ➝ Buy$206.00N/AView Rating Details
9/28/2017Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$165.00LowView Rating Details
9/18/2017JPMorgan Chase & Co.Reiterated RatingBuy$190.00LowView Rating Details
8/9/2017Janney Montgomery ScottReiterated RatingBuy$180.00 ➝ $192.00LowView Rating Details
5/22/2017Sanford C. BernsteinSet Price TargetMarket Perform$160.00 ➝ $176.00LowView Rating Details
(Data available from 4/24/2017 forward)
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Featured Article: What is a front-end load?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel